Table 2.
Case | Acylcarnitine C4 Labs Normal < 1.06 μmol/L | Ethylmalonic Acid Labs Normal = .5–20.20 μg/mg creatinine | Genotype Allele 1 | Genotype Allele 2 |
---|---|---|---|---|
Newborn Screened | ||||
Case 1 | 2.96 NBS 2.51 Repeat |
247.00 265.00 |
505A>C 625G>A |
505A>C 625G>A |
Case 2 | 2.0 NBS 1.77 Repeat 2.04 at follow-up |
330.93 | 319C>T | 319C>T |
Case 3 | 2.83 NBS 3.14 Repeat |
67.84 | 529T>C | 529T>C |
Case 4 | 2.6 NBS 2.33 Repeat |
249.17 | 319C>T | 319C>T |
Case 5 | 3.7 NBS 1.04 Repeat |
41.25 41.60 |
625G>A | 625G>A |
Case 6 | 2.11 NBS 1.93 Repeat 1.72 at follow-up |
Elevated (NA) | 319C>T | 991G>A |
Case 7 | 5.16 NBS 2.38 Repeat |
182.00 372.00 |
529T>C | 988C>T |
Case 8 | 2.86 NBS .96 Repeat |
118.00 | 625G>A | 988C>T |
Identified because of Clinical Symptoms | ||||
Case 9 | Normal NBS .35 at follow-up |
33.29 | 625G>A | 625G>A |
Case 10 | No NBS in state .74 Initial at 17 months .91 at follow-up 1.68 at follow-up |
38.98 | 625G>A | 625G>A |
Case 11 | Normal NBS | Normal | 625G>A | 511C>T |
Case 12 | No NBS in state 5.11 at follow-up |
30.00 | 625G>A | 511C>T |
Case 13 | No NBS in state 2.44 at follow-up 1.38 at follow-up |
24.28 | 625G>A 136C>T |
625G>A |
Case 14 | Normal NBS 1.09 at follow-up |
21.96 54.42 |
625G>A | 625G>A |
NBS = Newborn Screening